Beijing Tong Ren Tang Chinese Medicine Co Stock

Beijing Tong Ren Tang Chinese Medicine Co EBIT 2024

Beijing Tong Ren Tang Chinese Medicine Co EBIT

748.73 M HKD

Ticker

3613.HK

ISIN

HK0000145638

WKN

A1XDB1

In 2024, Beijing Tong Ren Tang Chinese Medicine Co's EBIT was 748.73 M HKD, a 21.08% increase from the 618.39 M HKD EBIT recorded in the previous year.

The Beijing Tong Ren Tang Chinese Medicine Co EBIT history

YEAREBIT (undefined HKD)
2026e1.01
2025e0.88
2024e0.75
20230.62
20220.81
20210.78
20200.67
20190.65
20180.7
20170.6
20160.53
20150.45
20140.34
20130.25
20120.11
20110.02

Beijing Tong Ren Tang Chinese Medicine Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Beijing Tong Ren Tang Chinese Medicine Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Beijing Tong Ren Tang Chinese Medicine Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Beijing Tong Ren Tang Chinese Medicine Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Beijing Tong Ren Tang Chinese Medicine Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Beijing Tong Ren Tang Chinese Medicine Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Beijing Tong Ren Tang Chinese Medicine Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Beijing Tong Ren Tang Chinese Medicine Co’s growth potential.

Beijing Tong Ren Tang Chinese Medicine Co Revenue, EBIT and net profit per share

DateBeijing Tong Ren Tang Chinese Medicine Co RevenueBeijing Tong Ren Tang Chinese Medicine Co EBITBeijing Tong Ren Tang Chinese Medicine Co Net Income
2026e2.05 B undefined1.01 B undefined802.61 M undefined
2025e1.89 B undefined880.35 M undefined734.3 M undefined
2024e1.66 B undefined748.73 M undefined627.57 M undefined
20231.52 B undefined618.39 M undefined540.39 M undefined
20221.73 B undefined811.58 M undefined645.88 M undefined
20211.56 B undefined778.46 M undefined607.84 M undefined
20201.32 B undefined669.4 M undefined542.46 M undefined
20191.43 B undefined651.99 M undefined556.12 M undefined
20181.51 B undefined698.01 M undefined580.72 M undefined
20171.27 B undefined597.68 M undefined489.97 M undefined
20161.08 B undefined527.5 M undefined420.32 M undefined
2015970.48 M undefined452.48 M undefined354.25 M undefined
2014761.05 M undefined343.52 M undefined287.12 M undefined
2013614 M undefined252.9 M undefined220 M undefined
2012333 M undefined113.7 M undefined155.9 M undefined
2011196.7 M undefined23.9 M undefined58.7 M undefined

Beijing Tong Ren Tang Chinese Medicine Co stock margins

The Beijing Tong Ren Tang Chinese Medicine Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing Tong Ren Tang Chinese Medicine Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing Tong Ren Tang Chinese Medicine Co.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Beijing Tong Ren Tang Chinese Medicine Co's sales revenue. A higher gross margin percentage indicates that the Beijing Tong Ren Tang Chinese Medicine Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Beijing Tong Ren Tang Chinese Medicine Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Beijing Tong Ren Tang Chinese Medicine Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Beijing Tong Ren Tang Chinese Medicine Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Beijing Tong Ren Tang Chinese Medicine Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Beijing Tong Ren Tang Chinese Medicine Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Beijing Tong Ren Tang Chinese Medicine Co Margin History

Beijing Tong Ren Tang Chinese Medicine Co Gross marginBeijing Tong Ren Tang Chinese Medicine Co Profit marginBeijing Tong Ren Tang Chinese Medicine Co EBIT marginBeijing Tong Ren Tang Chinese Medicine Co Profit margin
2026e68.67 %49.39 %39.13 %
2025e68.67 %46.65 %38.91 %
2024e68.67 %45.08 %37.78 %
202368.67 %40.55 %35.44 %
202266.44 %46.88 %37.31 %
202171.95 %50.02 %39.06 %
202072.45 %50.89 %41.24 %
201970.69 %45.51 %38.82 %
201871.24 %46.11 %38.36 %
201772.39 %47.21 %38.7 %
201673.33 %48.65 %38.76 %
201570.16 %46.62 %36.5 %
201471.35 %45.14 %37.73 %
201368.4 %41.19 %35.83 %
201270.9 %34.14 %46.82 %
201167.01 %12.15 %29.84 %

Beijing Tong Ren Tang Chinese Medicine Co Aktienanalyse

What does Beijing Tong Ren Tang Chinese Medicine Co do?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is one of the leading companies in the field of traditional Chinese medicine (TCM) and is headquartered in Beijing, China. The company was founded in 1669 and has a long history in the manufacturing of TCM products. The company has a versatile business model and is involved in various sectors. In addition to manufacturing TCM products, the company operates 30 retail stores in China and 24 internationally in countries such as the USA, Canada, Japan, and Singapore, to name a few. Tong Ren Tang also offers its products online and works with distributors and pharmacies worldwide. The company places great emphasis on quality and has invested in state-of-the-art production facilities in recent years to ensure the highest standards. Tong Ren Tang has not only improved TCM preparations but also produced a variety of dietary supplements, skincare products, herbal baths, and children's medications. TCM is a natural approach to treating diseases that dates back many centuries and is still popular among many people. Tong Ren Tang specializes in delivering TCM products of the highest quality. The products are manufactured under strict quality controls that ensure the purity and efficacy of the product. The company is known for its famous brand, "Tong Ren Tang," which is highly popular in China and around the world. Tong Ren Tang products are available in more than 50 countries worldwide and are appreciated by thousands of customers. In addition to their core competence in manufacturing TCM products and supplements, Tong Ren Tang has also developed other products, such as premium skincare products like Ginseng and Pearl Night Cream. To ensure effectiveness and safety, the company has been striving for centuries to achieve the highest standards by using high-quality and trusted raw materials. Tong Ren Tang is also committed to educating the public about the benefits of TCM and has conducted many radio advertisements and sponsored television shows through Pan-Asian channels in recent years. The company has also received various international awards and certifications such as GMP (Good Manufacturing Practice) and actively advocates for environmental protection and social responsibility. Overall, Beijing Tong Ren Tang is a unique company that seamlessly combines tradition and modern technology to produce top-quality TCM products. Tong Ren Tang's commitment to quality, effectiveness, and safety, as well as its promotion of the TCM industry, has helped expand understanding and access to TCM products worldwide. Beijing Tong Ren Tang Chinese Medicine Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Beijing Tong Ren Tang Chinese Medicine Co's EBIT

Beijing Tong Ren Tang Chinese Medicine Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Beijing Tong Ren Tang Chinese Medicine Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Beijing Tong Ren Tang Chinese Medicine Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Beijing Tong Ren Tang Chinese Medicine Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Beijing Tong Ren Tang Chinese Medicine Co stock

How much did Beijing Tong Ren Tang Chinese Medicine Co achieve in EBIT for the current year?

In the current year, Beijing Tong Ren Tang Chinese Medicine Co has achieved an EBIT of 748.73 M HKD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Beijing Tong Ren Tang Chinese Medicine Co.

How has the EBIT of Beijing Tong Ren Tang Chinese Medicine Co developed in recent years?

The EBIT of Beijing Tong Ren Tang Chinese Medicine Co has increased by 21.077% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Beijing Tong Ren Tang Chinese Medicine Co?

The EBIT of Beijing Tong Ren Tang Chinese Medicine Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Beijing Tong Ren Tang Chinese Medicine Co pay?

Over the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co paid a dividend of 0.66 HKD . This corresponds to a dividend yield of about 6.9 %. For the coming 12 months, Beijing Tong Ren Tang Chinese Medicine Co is expected to pay a dividend of 0.71 HKD.

What is the dividend yield of Beijing Tong Ren Tang Chinese Medicine Co?

The current dividend yield of Beijing Tong Ren Tang Chinese Medicine Co is 6.9 %.

When does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?

Beijing Tong Ren Tang Chinese Medicine Co pays a quarterly dividend. This is distributed in the months of November, June, July, July.

How secure is the dividend of Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co paid dividends every year for the past 13 years.

What is the dividend of Beijing Tong Ren Tang Chinese Medicine Co?

For the upcoming 12 months, dividends amounting to 0.71 HKD are expected. This corresponds to a dividend yield of 7.46 %.

In which sector is Beijing Tong Ren Tang Chinese Medicine Co located?

Beijing Tong Ren Tang Chinese Medicine Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Tong Ren Tang Chinese Medicine Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Tong Ren Tang Chinese Medicine Co from 6/24/2024 amounting to 0.33 HKD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Beijing Tong Ren Tang Chinese Medicine Co pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Beijing Tong Ren Tang Chinese Medicine Co in the year 2023?

In the year 2023, Beijing Tong Ren Tang Chinese Medicine Co distributed 0.53 HKD as dividends.

In which currency does Beijing Tong Ren Tang Chinese Medicine Co pay out the dividend?

The dividends of Beijing Tong Ren Tang Chinese Medicine Co are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beijing Tong Ren Tang Chinese Medicine Co

Our stock analysis for Beijing Tong Ren Tang Chinese Medicine Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Tong Ren Tang Chinese Medicine Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.